• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舌肌:在舌肌张力障碍中的临床应用

The tongue muscles: Clinical applications in lingual dystonia.

作者信息

Rosales Raymond L, Endaya Nadine J

机构信息

University of Santo Tomas, Faculty of Medicine & Surgery - Neurosciences and Research Center for Health Sciences, Philippines; Metropolitan Medical Center, Center for Neurodiagnostic and Therapeutic Services of Department of Neuroscience and Brain Health, Philippines; St. Luke's Medical Center, Institute of Neurosciences, Philippines.

Metropolitan Medical Center, Center for Neurodiagnostic and Therapeutic Services of Department of Neuroscience and Brain Health, Philippines; University of Santo Tomas Hospital, Department of Neuroscience and Behavioral Medicine, Manila, Philippines.

出版信息

Toxicon. 2025 Jul;262:108382. doi: 10.1016/j.toxicon.2025.108382. Epub 2025 May 9.

DOI:10.1016/j.toxicon.2025.108382
PMID:40334795
Abstract

Lingual dystonia, a type of oromandibular focal dystonia, involves sustained tongue contractions, often causing protrusion during actions such as speaking or chewing. It is classified as either primary or secondary, depending on the underlying cause. Botulinum neurotoxin (BoNT) is a recognized treatment for focal dystonias, including lingual dystonia. However, precise administration of BoNT can be challenging, limiting its efficacy and potentially causing adverse effects. This review focuses on selecting target muscles and using ultrasound guidance for accurate BoNT administration. Using ultrasound, with or without electromyography, a submental injection approach is employed to target the genioglossus and hyoglossus muscles, which are most affected in lingual dystonia. The suprahyoid muscles are critical anatomical considerations during submental injections to avoid aspiration. Additionally, as drooling is a common symptom of lingual dystonia, BoNT injections into the submandibular glands are also discussed. A case series with X-linked dystonia-parkinsonism was our way to clinically demonstrate BoNT injections in those with severe lingual dystonias.

摘要

舌肌张力障碍是口下颌局灶性肌张力障碍的一种,表现为舌头持续收缩,常在说话或咀嚼等动作时导致舌头前伸。根据潜在病因,它可分为原发性或继发性。肉毒杆菌神经毒素(BoNT)是治疗包括舌肌张力障碍在内的局灶性肌张力障碍的一种公认方法。然而,BoNT的精确注射具有挑战性,限制了其疗效,并可能导致不良反应。本综述重点关注靶肌肉的选择以及使用超声引导进行BoNT的精确注射。通过超声,无论是否结合肌电图,采用颏下注射法靶向舌肌和舌骨舌肌,这两块肌肉在舌肌张力障碍中受影响最大。在颏下注射时,舌骨上肌群是重要的解剖学考虑因素,以避免误吸。此外,由于流涎是舌肌张力障碍的常见症状,本文还讨论了向颌下腺注射BoNT。一个X连锁肌张力障碍-帕金森综合征的病例系列是我们临床上展示对严重舌肌张力障碍患者进行BoNT注射的方式。

相似文献

1
The tongue muscles: Clinical applications in lingual dystonia.舌肌:在舌肌张力障碍中的临床应用
Toxicon. 2025 Jul;262:108382. doi: 10.1016/j.toxicon.2025.108382. Epub 2025 May 9.
2
The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.化学去神经支配在 X 连锁型肌张力障碍-帕金森病中的广泛应用(第二部分):使用肉毒毒素 A(Dysport®)注射治疗口颌部、舌部和躯干-脊柱部肌张力障碍的开放性经验。
Int J Neurosci. 2011;121 Suppl 1:44-56. doi: 10.3109/00207454.2011.558260.
3
Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.基于临床特征的个体化注射方法治疗舌部肌张力障碍的肉毒毒素治疗。
Toxins (Basel). 2019 Jan 17;11(1):51. doi: 10.3390/toxins11010051.
4
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.肉毒杆菌神经毒素A治疗口下颌肌张力障碍的疗效与安全性:一项荟萃分析
J Neural Transm (Vienna). 2019 Feb;126(2):141-148. doi: 10.1007/s00702-018-1960-7. Epub 2019 Jan 2.
5
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.肉毒毒素治疗眼睑痉挛和口下颌肌张力障碍。
Toxins (Basel). 2020 Apr 22;12(4):269. doi: 10.3390/toxins12040269.
6
Botulinum toxins in the treatment of primary focal dystonias.肉毒毒素治疗原发性局灶性肌张力障碍。
J Neurol Sci. 2012 May 15;316(1-2):9-14. doi: 10.1016/j.jns.2012.01.019. Epub 2012 Feb 14.
7
Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.用于治疗局限性肌张力障碍的肉毒杆菌神经毒素:临床试验中使用的评级工具综述
Toxicon. 2015 Dec 1;107(Pt A):89-97. doi: 10.1016/j.toxicon.2015.09.010. Epub 2015 Sep 10.
8
[Botulinum toxin for treatment of the focal dystonia].[肉毒杆菌毒素用于治疗局限性肌张力障碍]
Rinsho Shinkeigaku. 2017 Jul 29;57(7):367-372. doi: 10.5692/clinicalneurol.cn-001018. Epub 2017 Jul 24.
9
Update on the Use of Botulinum Toxin Therapy for Focal and Task-Specific Dystonias.肉毒杆菌毒素治疗局灶性和任务特异性肌张力障碍的最新进展
Semin Neurol. 2016 Feb;36(1):41-6. doi: 10.1055/s-0035-1571211. Epub 2016 Feb 11.
10
Systematic review of botulinum toxin treatment for oromandibular dystonia.肉毒杆菌毒素治疗口下颌肌张力障碍的系统评价
Toxicon. 2018 Jun 1;147:96-99. doi: 10.1016/j.toxicon.2018.02.006. Epub 2018 Feb 14.